Abstract
Loss of muscle mass and function in advanced liver disease has become a topic of rapidly growing interest since reports relating frailty and sarcopenia to risk of adverse liver transplant outcomes began to appear 7 years ago. Our current rapid growth in understanding of the problem has allowed the emergence of robust new opportunities for basic and clinical research that promise to improve the outcomes and quality of life of patients with cirrhosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Patel VC, White H, Støy S, et al. Clinical science workshop: targeting the gut-liver-brain axis. Metab Brain Dis. 2016;31:1327–37.
Bhanji RA, Narayanan P, Allen AM, et al. Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in NASH. Hepatology. 2017;66:2055–65.
Simon L, Jolley SE, Molina PE. Alcoholic myopathy: pathophysiologic mechanisms and clinical implications. Alcohol Res. 2017;38:207–17.
Acharya C, Bajaj JS. The microbiome in cirrhosis and its complications. Clin Gastroenterol Hepatol. 2019;17:307–21.
Ticinesi A, Lauretani F, Milani C, et al. Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: is there a gut–muscle axis? Nutrients. 2017;9:1303.
Reiberger T, Mandorfer M. Beta adrenergic blockade and decompensated cirrhosis. J Hepatol. 2017;66:849–59.
Jacobson GA, Fawcett JP. Beta2-agonist doping control and optical isomer challenges. Sports Med. 2016;46:1787–95.
Kandilis AN, Papadopoulou IP, Koskinas J, et al. Liver innervation and hepatic function: new insights. J Surg Res. 2015;194:511–9.
Dasarathy S, Hatzgolou M. Hyperammonemia and proteostasis in cirrhosis. Curr Opin Clin Nutr Metab Care. 2018;21:30–6.
Davuluri G, Krowkowski D, Guan BJ, et al. Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of L-leucine in cirrhosis. J Hepatol. 2016;65:929–37.
Carey EJ, Lai JC, Wang CW, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017;23:625–33.
Lai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66:564–74.
Dunn MA, Josbeno DA, Schmotzer AR, et al. The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates. Liver Transpl. 2016;22:1324–32.
Cawthon PM, Orwoll ES, Peters KE, et al. Strong relation between muscle mass determined by D3-creatine dilution, physical performance and incidence of falls and mobility limitations in a prospective cohort of older men. J Gerontol A Biol Sci Med Sci. 2019;74(6):844–52.
Carey EJ, Steidley DE, Aqel BA, et al. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl. 2010;16:1373–8.
Berzigotti A, Albillos A, Villanueva C, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology. 2017;65:1293–305.
Lai JC, Segev DL, McCulloch CE, et al. Physical frailty after liver transplantation. Am J Transplant. 2018;18:1986–94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dunn, M.A. (2020). A Research Wish List to Understand, Diagnose, and Manage Frailty and Sarcopenia. In: Tandon, P., Montano-Loza, A. (eds) Frailty and Sarcopenia in Cirrhosis. Springer, Cham. https://doi.org/10.1007/978-3-030-26226-6_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-26226-6_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26225-9
Online ISBN: 978-3-030-26226-6
eBook Packages: MedicineMedicine (R0)